发布日期：2014-06-30
英文标题：KASL clinical practice guidelines: Management of Hepatitis C
来源：Clin Mol Hepatol, 2014, 20(2): 89-136
Practice Guidelines for Management of Hepatitis C were first established in 2004. Since then, many study results have been published concerned with epidemiology, clinical outcomes and related factors, concept of response-guided therapy, therapeutic strategy, and results. Moreover, as direct acting antivirals (DAA) have been recently developed and adapted to practice, treatment of hepatitis C is rapidly evolving. Therefore, the Korean Association for the Study of the Liver (KASL) revised the guidelines based on a systematic approach that reflects evidence-based medicine and expert opinions.
